Full-Time

Scientist – Product Development

Posted on 9/3/2025

Cardinal Health

Cardinal Health

Distributes pharmaceuticals and medical products globally

Compensation Overview

$79.7k - $113.8k/yr

Company Does Not Provide H1B Sponsorship

Indianapolis, IN, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Bachelor's degree in related field, or equivalent work experience, preferred.
  • At least 5 years of experience working in a GMP environment in the pharmaceutical or biotechnology industry highly preferred.
  • A background in product research and development preferred.
  • Foundational expertise in the setup, operation, and maintenance of conventional analytical instrumentation (HPLC/GC/TLC/etc.) and modern chromatography data systems.
  • Ability to work in a controlled environment requires special attention to environmental, health, and safety regulations.
  • Position may require lifting or moving equipment weighing up to 40 lbs.
  • Commitment to maintain data integrity through strict adherence to standardized procedures and relevant compliance requirements, including the ability to clearly document all work activities in a timely manner.
  • Motivation to work effectively and cooperatively with others, and to establish and maintain good working relationships.
  • Desire to create, develop, and mature processes, and facility and systems infrastructure, to streamline operational efficiency across a broad range of products.
  • Flexibility to work periodic off-shift hours to accommodate routine production schedules among qualified facilities.
Responsibilities
  • This position will be responsible for the adaptation, setup, transfer, and maintenance of sponsor drug products with strict adherence to cGMP, GDP, environmental health and safety and related guidelines, and internal policies and procedures.
  • Specific duties will at a minimum comprise technical evaluation, material selection, process equipment configuration, document creation, and process validation, as well as occasional testing activities typical for a cGMP pharmaceutical manufacturing operation, including the preparation of chemicals and components, the operation/maintenance/repair of laboratory equipment, and the execution of standard operating procedures for routine testing of radiopharmaceutical products.
  • Evaluate, create, adapt, and transfer testing procedures established by internal product development teams and external product sponsors for our Indianapolis Theranostics cGMP radiopharmaceutical manufacturing facilities.
  • Generate study protocols and controlled documentation necessary to enable the technology transfer and qualification of contracted products.
  • Execute testing activities required for analytical method validation according to study protocols and standard operating procedures. Generate study reports where required.
  • Complete equipment qualification and computer system validation protocols developed in partnership with Validations personnel.
  • Lead investigations and document deviations and exceptions occurring during technology transfer.
  • Train facility personnel on new procedures and provide routine support following completion of technology transfer.
  • Facilitate day-to-day operation, maintenance and repair of testing instrumentation. Clean and maintain all testing and related laboratory equipment during technology transfer.
  • Communicate all issues related to safety, quality, and compliance to leadership.
Desired Qualifications
  • A background in product research and development preferred.

Cardinal Health distributes pharmaceuticals and manufactures medical and laboratory products for hospitals, clinics, and pharmacies worldwide. The company operates a global logistics network to deliver supplies while providing data tools that help healthcare facilities track inventory and improve operational efficiency. Unlike many niche suppliers, Cardinal Health combines 50 years of experience with a massive scale that covers both the physical supply chain and the software needed to manage it. Its goal is to streamline the healthcare supply chain to ensure providers have reliable access to essential products while reducing costs and improving patient care.

Company Size

N/A

Company Stage

N/A

Total Funding

$270.6M

Headquarters

Dublin, California

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • Majority stake in GI Alliance in November 2024 accelerates gastroenterology growth.
  • Acquired Advanced Diabetes Supply Group in November 2024 boosts at-Home Solutions.
  • Added Solaris Health urology MSO in August 2025 to Specialty Alliance platform.

What critics are saying

  • McKesson erodes specialty share with superior pharmacy analytics within 12-24 months.
  • Cencora undercuts generics pricing, squeezing margins in 6-12 months.
  • DEA quotas cut $500M opioid revenue comprising 20% sales in 3-6 months.

What makes Cardinal Health unique

  • Acquired Specialty Networks in January 2024 for multi-specialty GPOs in urology and gastroenterology.
  • Launched Kendall DL™ Multi System in June 2025 for continuous vital signs monitoring.
  • Expanded Actinium-225 production in April 2026 for novel cancer therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Health Savings Account/Flexible Spending Account

401(k) Retirement Plan

401(k) Company Match

Short- and Long-term Disability Coverage

Paid Parental Leave

Wellness Program

Company News

PR Newswire
Jan 31st, 2024
Cardinal Health To Acquire Specialty Networks And Its Pps Analytics Platform, A Technology Enabled Multi-Specialty Group Purchasing And Practice Enhancement Organization In Urology, Rheumatology And Gastroenterology

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices. Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas. Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ NetworkDUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for $1.2B in cash. Specialty Networks creates clinical and economic value for independent specialty providers and partners across multiple specialty GPOs: UroGPO, Gastrologix and GastroGPO, and United Rheumatology

intelligence360
Mar 7th, 2023
Cardinal Health To Spend $3,100,000.00 To Occupy 3,794 Square Feet Of Space In Indianapolis Indiana.

Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana. Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana.Indianapolis, Indiana — According to state and local economic development sources, Cardinal Health plans to invest $3,100,000.00 to build out 3,794 square feet of new space in Indianapolis. The company plans to occupy the new space at 7736 Zionsville Rd in Indianapolis, on or about September 1, 2023. According to the company website Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world

GlobeNewswire
Jul 26th, 2022
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients

Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem...

PR Newswire
Jan 10th, 2022
Medically Home Announces a $110 Million Strategic Investment Led by Baxter International Inc., Global Medical Response and Cardinal Health to Advance Leadership in Hospital-Level Patient Care at Home

/PRNewswire/ -- Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global...

INACTIVE